T he Brutalist director Brady Corbet is hopeful that the success of his historical epic, which stars Adrien Brody as ...

Oppenheimer analysts adjusted their outlook on Agilysys Inc (NASDAQ:AGYS), reducing the price target on the company's stock ...

Viking Therapeutics Inc.’s stock jumped 3% Tuesday, after a bullish note from Oppenheimer highlighted the company’s promising ...

Casting rumors for the Harry Potter TV reboot have been heating up over the past few months, with plenty of names for Snape ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Notably, analysts at Oppenheimer consider Nvidia as the chip stock to own for 2025. In a client note, Oppenheimer highlighted ...

Masco Corp (MAS) stock saw a modest uptick, ending the day at $78.2 which represents a slight increase of $0.65 or 0.84% from the prior close of $77.55. The stock opened at $78.21 and touched a low of ...

As previously reported, Oppenheimer analyst Brian Schwartz downgraded Pros Holdings (PRO) to Perform from Outperform and removed the firm’s ...

Oppenheimer has chosen its top stock picks for 2025 while the semiconductor sector gets up for a crucial earnings season.

R Madhavan about his working philosophies, his disappointment with recent Hollywood films including Christopher Nolan’s ...

Jay Olson, an analyst from Oppenheimer, maintained the Buy rating on Viking Therapeutics (VKTX – Research Report). The associated price target ...